|
| 37740921 | Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network. | Alzheimers Dement | 2024 |
| 37634955 | "And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure. | Am J Geriatr Psychiatry | 2024 |
| 36251323 | Metabolomic and lipidomic signatures in autosomal dominant and late-onset Alzheimer's disease brains. | Alzheimers Dement | 2023 |
| 37867465 | T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease. | Hum Brain Mapp | 2023 |
| 37961586 | Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease. | bioRxiv | 2023 |
| 37843849 | Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. | JAMA Neurol | 2023 |
| 37942088 | Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. | Brain Commun | 2023 |
| 35609137 | Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease. | Alzheimers Dement | 2023 |
| 35362200 | Biomarker clustering in autosomal dominant Alzheimer's disease. | Alzheimers Dement | 2023 |
| 37291760 | Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. | Aging Cell | 2023 |
| 37085492 | Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers. | Nat Commun | 2023 |
| 37016671 | Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer disease. | medRxiv | 2023 |
| 37231491 | Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [<sup>18</sup>F]flortaucipir study. | Alzheimers Res Ther | 2023 |
| 37202169 | Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Life Span. | Neurology | 2023 |
| 37429916 | Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). | Nat Neurosci | 2023 |
| 36625756 | Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease. | Brain | 2023 |
| 36522155 | First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study. | J Neurol Neurosurg Psychiatry | 2023 |
| 36919987 | Lecanamab Ushers in a New Era of Anti-Amyloid Therapy for Alzheimer's Disease. | Ann Neurol | 2023 |
| 36843330 | Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease. | Ann Neurol | 2023 |
| 36576155 | Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. | Alzheimers Dement | 2023 |
| 36640138 | Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease. | Alzheimers Dement | 2023 |
| 36798226 | MS4A4A modifies the risk of Alzheimer disease by regulating lipid metabolism and immune response in a unique microglia state. | medRxiv | 2023 |
| 35241502 | Resilience at High Resolution: Proteomics in the Study of Brain Reserve. | Neurology | 2022 |
| 35678397 | Alzheimer Disease. | Continuum (Minneap Minn) | 2022 |
| 35580594 | Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology. | Brain | 2022 |
| 35783127 | Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials. | Front Aging Neurosci | 2022 |
| 35358703 | CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease. | Neurobiol Dis | 2022 |
| 36544184 | Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study. | Alzheimers Res Ther | 2022 |
| 36238934 | Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's disease. | Front Aging Neurosci | 2022 |
| 35925685 | Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. | Brain | 2022 |
| 36348972 | Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. | Alzheimers Dement (Amst) | 2022 |
| 36189728 | Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network. | Ann Clin Transl Neurol | 2022 |
| 36151869 | Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. | Ann Neurol | 2022 |
| 35099506 | Association of BDNF Val66Met With Tau Hyperphosphorylation and Cognition in Dominantly Inherited Alzheimer Disease. | JAMA Neurol | 2022 |
| 34854530 | Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer disease. | Alzheimers Dement | 2022 |
| 35246267 | Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease. | Acta Neuropathol Commun | 2022 |
| 35065037 | Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. | Lancet Neurol | 2022 |
| 35212149 | Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease. | Alzheimers Dement | 2022 |
| 30899092 | The BDNF<sub>Val66Met</sub> SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. | Mol Psychiatry | 2021 |
| 33495373 | Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease. | Neurology | 2021 |
| 33725114 | Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. | Brain | 2021 |
| 34494019 | Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer's disease. | bioRxiv | 2021 |
| 34548654 | The case for low-level BACE1 inhibition for the prevention of Alzheimer disease. | Nat Rev Neurol | 2021 |
| 34155411 | A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. | Nat Med | 2021 |
| 34319442 | Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. | Acta Neuropathol | 2021 |
| 34289882 | The informed road map to prevention of Alzheimer Disease: A call to arms. | Mol Neurodegener | 2021 |
| 33226734 | Dominantly inherited Alzheimer's disease in Latin America: Genetic heterogeneity and clinical phenotypes. | Alzheimers Dement | 2021 |
| 33430685 | Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease. | Brain Connect | 2021 |
| 33480178 | Modeling autosomal dominant Alzheimer's disease with machine learning. | Alzheimers Dement | 2021 |
| 32522711 | Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. | Neurobiol Dis | 2020 |